Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Neoadjuvant chemotherapy in 13 patients with locally advanced poorly differentiated thyroid carcinoma based on Turin proposal : a single institution experience
Avtorji:ID Bešić, Nikola (Avtor)
ID Dremelj, Marta (Avtor)
ID Schwarzbartl-Pevec, Andreja A. (Avtor)
ID Gazić, Barbara (Avtor)
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (459,46 KB)
MD5: 01FC3E9A3DEF9521E783FA0F03210CA4
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo OI - Onkološki inštitut Ljubljana
Povzetek:There is a paradigm that chemotherapy is ineffective in thyroid carcinoma. The aim of our study was to find out whether neoadjuvant chemotherapy before thyroid surgery had an effect on the size of primary tumour in patients with poorly differentiated thyroid carcinoma (PDTC) based on Turin proposal. Patients and methods. Altogether, 13 patients (8 women, 5 men; median age 61 years) with PDTC based on Turin proposal were treated with neoadjuvant chemotherapy between 1986 and 2005. Tumour diameter was from 4.5 to 18 cm (median 9 cm). Regional and distant metastases were detected in 6 and 9 patients, respectively. Eight patients had pT4 tumour. Results. Altogether, 29 (range 1%5) cycles of chemotherapy were given. Tumour diameter decreased in all the patients and by more than 30% in 5 patients (= 38%). Two of these five patients had also preoperative external beam irradiation (EBRT). Total thyroidectomy, lobectomy and neck dissection were performed in 10, 3 and 5 cases, respectively. R0 and R1 resection was done in 5 and 8 cases, respectively. Eight patients had postoperative EBRT of the neck and upper mediastinum. The 5-year and 10-year cause-specific survival rates of patients were 66% and 20%, respectively. Conclusions. After neoadjuvant chemotherapy a partial tumour regression was observed in 38% of patients with PDTC based on Turin proposal.
Ključne besede:poorly differentiated thyroid carcinoma, neoadjuvant, chemotherapy, survival
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Datum objave:01.09.2015
Založnik:Association of Radiology and Oncology
Leto izida:2015
Št. strani:str. 271-278, V
Številčenje:Vol 49, no. 3
Izvor:Ljubljana
PID:20.500.12556/DiRROS-18788 Novo okno
UDK:616.4
ISSN pri članku:1318-2099
DOI:10.1515/raon-2015-0001 Novo okno
COBISS.SI-ID:2077051 Novo okno
Avtorske pravice:by Authors
Datum objave v DiRROS:22.04.2024
Število ogledov:47
Število prenosov:17
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Radiology and oncology
Skrajšan naslov:Radiol. oncol.
Založnik:Slovenian Medical Society - Section of Radiology, Croatian Medical Association - Croatian Society of Radiology
ISSN:1318-2099
COBISS.SI-ID:32649472 Novo okno

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:slabo diferencirani rak ščitnice, neoadjuvantno zdravljenje, kemoterapija, preživetje


Nazaj